Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.

Pharmaceutical

Orasis Pharmaceuticals

Elad Kedar

Yaron Shimon

Merav Zeide

Ilan Rubin

Paul Smith

Iris Meisner

Ron Neumann

Sharon Amzel-Sasson

The board of directors at Orasis Pharmaceuticals has a history of experience with various companies and organizations in the field of economics, business administration, marketing, finance, and general surgery. They have also been educated at some of the world's most prestigious universities, including Tel Aviv University, the University of Southern California, UC Santa Barbara, and the University of St.Gallen.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Orasis Pharmaceuticals

Leadership Team

CEO and Executive Team